Response to Deng et al.'s LRRK2 patent review

被引：1
|
作者：
Burdick, Daniel Jon [1 ]
机构：
[1] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2013年 / 23卷 / 02期
关键词：
kinase; LRRK2; parkinson's disease; small molecule; INHIBITORS; DISCOVERY;
D O I：
10.1517/13543776.2013.757594
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：279 / 279
页数：1
相关论文
共 50 条
  • [1] REPLY TO ZHANG ET AL.: The differential role of LRRK2 variants in nested leprosy phenotypes
    Fava, Vinicius M.
    Cobat, Aurelie
    Gzara, Chaima
    Alcais, Alexandre
    Abel, Laurent
    Schurr, Erwin
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (19) : 10124 - 10125
  • [2] Response to "Response to review by Pan et al."
    Pan, Xin-Hui
    Chin, Yip Han
    Chan, Mark Y.
    Chew, Nicholas W. S.
    [J]. OBESITY, 2024, 32 (09) : 1605 - 1606
  • [3] Response to review by Herod et al.
    Ames, WA
    Levine, MF
    [J]. PAEDIATRIC ANAESTHESIA, 2003, 13 (04): : 370 - 371
  • [4] Response to review by Pan et al.
    Holmback, Ulf
    [J]. OBESITY, 2024, 32 (09) : 1603 - 1604
  • [5] Authors' replies to the comments of Koga et al. on "Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease"
    Hickman, Richard A.
    Vonsattel, Jean-Paul
    Agin-Liebes, Julian
    Marder, Karen
    Alcalay, Roy N.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : 131 - 132
  • [6] Revisiting Deng et al.’s Multiparty Quantum Secret Sharing Protocol
    Tzonelih Hwang
    Cheng-Chieh Hwang
    Chun-Wei Yang
    Chuan-Ming Li
    [J]. International Journal of Theoretical Physics, 2011, 50 : 2790 - 2798
  • [7] Revisiting Deng et al.'s Multiparty Quantum Secret Sharing Protocol
    Hwang, Tzonelih
    Hwang, Cheng-Chieh
    Yang, Chun-Wei
    Li, Chuan-Ming
    [J]. INTERNATIONAL JOURNAL OF THEORETICAL PHYSICS, 2011, 50 (09) : 2790 - 2798
  • [8] In response to Murphy et al., Lower et al., and Lan et al.
    Conrad, B
    [J]. CELL, 1998, 95 (01) : 16 - 16
  • [9] Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson's disease: a patent review of the literature to date
    Morez, Margaux
    Ordonez, Antonio Jesus Lara
    Melnyk, Patricia
    Liberelle, Maxime
    Lebegue, Nicolas
    Taymans, Jean-Marc
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (09) : 773 - 788
  • [10] Response to Rose et al. and Petersen et al.
    [J]. Stadmark, J. (Johanna.Stadmark@geol.lu.se), 2012, Elsevier Ltd, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom (64)
12345